RVMD
Revolution Medicines, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +20.0% ·
flujo de acciones -2.6% ·
nuevas posiciones netas +16.7%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 149 | +17 | 106.81M | $18.63B | +25 | −7 |
| Q1 2026 | 134 | +17 | 103.45M | $9.43B | +22 | −6 |
| Q4 2025 | 116 | +1 | 107.70M | $8.12B | +3 | −1 |
| Q3 2025 | 20 | +3 | 68.96M | $3.10B | +3 | −1 |
| Q2 2025 | 15 | 0 | 63.88M | $2.26B | — | — |
| Q1 2025 | 12 | +2 | 32.32M | $1.05B | +2 | — |
| Q4 2024 | 10 | -1 | 33.19M | $1.34B | — | −1 |
| Q3 2024 | 10 | -1 | 26.28M | $1.08B | — | −1 |
| Q2 2024 | 11 | — | 28.23M | $999.53M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 11.79M | +8.9% | $416.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (pasivo) | 5.80M | +0.2% | $205.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 6.20M | -4.2% | $198.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 6.20M | -4.2% | $198.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 6.20M | -4.2% | $198.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Geode Capital Management ✦ (pasivo) | 4.14M | +1.4% | $146.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 4.14M | +1.4% | $146.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Norges Bank ✦ (pasivo) | 1.40M | -19.4% | $49.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 894.00K | -22.3% | $13.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 894.00K | -22.3% | $13.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 187.19K | -87.6% | $6.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 156.35K | Nuevo | $5.53M | 0.0% | New | 1 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 142.80K | Nuevo | $5.05M | 0.0% | New | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 133.07K | -2.9% | $4.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 133.07K | -2.9% | $4.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 12.14K | -21.9% | $429,307 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 12.14K | -21.9% | $429,307 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 12.14K | -21.9% | $429,307 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 12.14K | -21.9% | $429,307 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 1.45M | -1.0% | $55,286 | 0.0% | ▼ Trim | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $5.53M | 0.0% |
| Renaissance Technologies | $5.05M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 13.50K acciones, $1,312 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 3.40K acc. · $704,603
Officer · 17.32K acc. · $3.61M
Officer · 25.82K acc. · $5.40M
Officer · 2.54K acc. · $534,072
Officer · 4.50K acc. · $951,038
Officer · 3.31K acc. · $702,761
Officer, Director · 5.13K acc. · $1.06M
Officer, Director · 24.92K acc. · $5.19M
Officer, Director · 35.94K acc. · $7.52M
Officer, Director · 3.81K acc. · $801,670
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología